CHM 10.5% 2.1¢ chimeric therapeutics limited

Stunning presentation. Looks like massive delays with the GBM...

  1. 1,439 Posts.
    lightbulb Created with Sketch. 486
    Stunning presentation.

    Looks like massive delays with the GBM trial. Reworking the whole design to include IV delivery for first dose and adding in chemo.

    Disappointed we won't see any further GBM results for a long time (probably 2026), especially since the data to date has been so compelling.

    CDH17 now officially the lead candidate. The cohort patient numbers are not at all clear. I take it 15 patients is all dose escalation. And then dose expansion - will they make up the phase 2 patient numbers?
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.002(10.5%)
Mkt cap ! $18.39M
Open High Low Value Volume
2.0¢ 2.1¢ 2.0¢ $30.13K 1.439M

Buyers (Bids)

No. Vol. Price($)
6 623541 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 423206 1
View Market Depth
Last trade - 15.53pm 25/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.